These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 5481731)
1. Excretion of [6-14C]megestrol acetate (6 methyl-17 acetoxypregna-4,6 diene, 3,20 dione) released from subcutaneous silastic implants in women. Coutinho EM; Ferreira DA; Prates H; Kincl F J Reprod Fertil; 1970 Nov; 23(2):345-7. PubMed ID: 5481731 [No Abstract] [Full Text] [Related]
2. Sustained release hormonal preparations. 5. Absorption of 6-methyl-17-alpha-acetoxypregna-4,6-diene-3,20-dione from polydimethylsiloxane implants in vivo. Benagiano G; Ermini M; Chang CC; Sundaram K; Kincl FA Acta Endocrinol (Copenh); 1970 Jan; 63(1):29-38. PubMed ID: 5467019 [No Abstract] [Full Text] [Related]
3. Acceptability of long-term contraceptive steroid administration in humans by subcutaneous Silastic capsules. Tatum HJ; Coutinho EM; Filho JA; Sant'anna AR Am J Obstet Gynecol; 1969 Dec; 105(7):1139-43. PubMed ID: 5352595 [No Abstract] [Full Text] [Related]
4. Fertility control in women with a progestogen released in microquantities from subcutaneous capsules. Croxatto H; Díaz S; Vera R; Etchart M; Atria P Am J Obstet Gynecol; 1969 Dec; 105(7):1135-8. PubMed ID: 5352594 [No Abstract] [Full Text] [Related]
5. The excretion of megestrol acetate by beagle bitches. Chainey D; McCoubrey A; Evans JM Vet Rec; 1970 Mar; 86(10):287-8. PubMed ID: 5461594 [No Abstract] [Full Text] [Related]
6. The metabolism of megestrol acetate (17-alpha-acetoxy-6-methylpregna-4,6-diene-3,20-dione) in women. Cooper JM; Kellie AE Steroids; 1968 Feb; 11(2):133-49. PubMed ID: 5636707 [No Abstract] [Full Text] [Related]
8. Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants. 1. Diffusion of megestrol acetate in humans. Benagiano G; Ermini M; Carenza L; Rolfini G Acta Endocrinol (Copenh); 1973 Jun; 73(2):335-46. PubMed ID: 4740833 [No Abstract] [Full Text] [Related]
9. Long-term effect of a continuous low dose of megestrol acetate on the genital organs and fertility of female rats. Sanwal PC; Pande JK; Dasgupta PR; Kar AB; Setty BS Steroids; 1970 May; 15(5):711-22. PubMed ID: 5432987 [TBL] [Abstract][Full Text] [Related]
10. Microdose intrauterine progestagen associated with intrauterine contraceptive devices. Horne HW; Scott JM; Underwood RH Int J Fertil; 1970; 15(4):210-3. PubMed ID: 5487545 [TBL] [Abstract][Full Text] [Related]
11. Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants. 2. Maintenance of ovarian function in patients with megestrol acetate implants. Benagiano G; Ermini M; Carenza L; Donini P Acta Endocrinol (Copenh); 1973 Jun; 73(2):347-59. PubMed ID: 4740834 [TBL] [Abstract][Full Text] [Related]
12. [Clinical test with a prolonged-action estrogen-progesterone combination administered intramuscularly]. Mateos Cándano M; Ochoa Bernal MR; Ruiz Moreno JA Ginecol Obstet Mex; 1969 Sep; 26(155):275-82. PubMed ID: 5402846 [No Abstract] [Full Text] [Related]
13. Estrus control in swine through management and by the oral administration of megestrol acetate. Norrish JG; Burgess TD Can Vet J; 1968 May; 9(5):116-9. PubMed ID: 5689809 [No Abstract] [Full Text] [Related]
14. [Control of fertility using micro-doses of megestrol acetate]. Avendaño S Rev Chil Obstet Ginecol; 1969; 33(4):238-52. PubMed ID: 5355547 [No Abstract] [Full Text] [Related]
15. Use of megestrol acetate in the treatment of miliary eczema in the cat. Turner WT Vet Rec; 1971 Mar; 88(12):315-6. PubMed ID: 5102613 [No Abstract] [Full Text] [Related]
16. Studies on physiology & biochemistry of cervix: response of rat cervix to a continuous low dose of megestrol acetate. Sanwal PC; Mehrotra PK; Karkun JN; Dasgupta PR; Kar AB Indian J Exp Biol; 1970 Oct; 8(4):326-7. PubMed ID: 5533834 [TBL] [Abstract][Full Text] [Related]